HALO

$122.965.66%-7.38

After Hours: 114.02-8.94 -7.27%

Halozyme Therapeutics Inc (HALO)

Halozyme Therapeutics Inc Stock (HALO) Forecast

The Halozyme Therapeutics Inc (HALO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $131.66, representing a +7.07% increase from the current price of $122.96. The highest analyst price target is $137.24, and the lowest is $126.08.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month HALO Price Target

Average 151.14 (+22.92% Upside)

Is Halozyme Therapeutics Inc (HALO) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	52.34	Neutral
STOCH(9,6)	57.38	Neutral
STOCHRSI(14)	26.48	Neutral
MACD(12,26)	4.39	Sell
ADX(14)	36.41	Buy
William %R	-89.16	Buy
CCI(14)	-14.11	Neutral

Buy: 2 · Sell: 1 · Neutral: 4Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	128.51 Sell	127.04 Sell
MA20	123.63 Sell	123.98 Sell
MA50	115.26 Buy	115.32 Buy
MA100	100.28 Buy	104.05 Buy
MA200	84.50 Buy	91.45 Buy

Buy: 6 · Sell: 4 · Neutral: 0Summary: Buy

According to our latest analysis, HALO could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 5 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on HALO, as trading bullish markets is always a lot easier

RSI (Relative Strength Index): The RSI(14) value of 52.34 indicates that HALO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 57.38 indicates that HALO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.48 indicates that HALO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 36.41 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of -14.11 indicates that HALO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term HALO price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Halozyme Therapeutics Inc financial reports and earnings history, Halozyme Therapeutics Inc (HALO) stock could reach $312.28 by 2030, $637.47 by 2040 and $792.19 by 2050. See the projected annual prices until 2050 of the Halozyme Therapeutics Inc stock below:

Halozyme Therapeutics Inc (HALO) is expected to reach an average price of $495.62 in 2035, with a high prediction of $504.99 and a low estimate of $405.33. This indicates an +303.08% change from the last recorded price of $122.96.
Halozyme Therapeutics Inc (HALO) stock is projected to chart a bullish course in 2040, with an average price target of $636.64, representing an +417.76% change from its current level. The forecast ranges from a conservative $517.41 to a sky-high $637.47.
Our analysts predict Halozyme Therapeutics Inc (HALO) to change +494.65% by 2045, soaring from $597.97 to an average price of $731.19, potentially reaching $732.12. While $597.97 is the low estimate, the potential upside is significant.
Halozyme Therapeutics Inc (HALO) stock is expected to climb by 2050, reaching an average of $790.25, a +542.69% change from its current level. However, a wide range of estimates exists, with high and low targets of $792.19 and $598.28, respectively, highlighting the market's uncertainty.

Halozyme Therapeutics Inc Stock (HALO) Year by Year Forecast

Halozyme Therapeutics Inc Stock (HALO) Price Forecast for 2026

The predicted value for Halozyme Therapeutics Inc (HALO) in 2026 is set at an average of $92.32. Estimates vary from a peak of $137.24 to a trough of $61.33, indicating an -24.92% surge from the present price of $122.96.

Month	Average	Low	High	Change from today's price
December, 2026	$136.71	$126.08	$137.24	+11.18%

Halozyme Therapeutics Inc Stock (HALO) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Halozyme Therapeutics Inc (HALO) is $158.57, with a high forecast of $183.32 and a low forecast of $131.46. This indicates an +28.96% increase from the last price of $122.96.

Month	Average	Low	High	Change from today's price
January, 2027	$133.26	$132.43	$140.25	+8.38%
February, 2027	$136.48	$131.46	$138.32	+10.99%
March, 2027	$140.63	$135.61	$142.38	+14.37%
April, 2027	$150.43	$140.64	$150.58	+22.34%
May, 2027	$151.69	$150.61	$156.46	+23.37%
June, 2027	$161.34	$150.13	$163.94	+31.21%
July, 2027	$165.16	$159.72	$166.80	+34.32%
August, 2027	$171.39	$162.84	$173.42	+39.39%
September, 2027	$167.06	$165.95	$174.62	+35.87%
October, 2027	$169.11	$165.65	$169.29	+37.53%
November, 2027	$175.51	$167.19	$176.21	+42.74%
December, 2027	$180.84	$175.48	$183.32	+47.07%

Halozyme Therapeutics Inc Stock (HALO) Price Forecast for 2028

In 2028, Halozyme Therapeutics Inc (HALO) is projected to reach an average price of $197.79, with a high projection of $213.18 and a low estimate of $180.18. This indicates an +60.86% rise from the last price of $122.96.

Month	Average	Low	High	Change from today's price
January, 2028	$197.32	$180.18	$197.34	+60.47%
February, 2028	$197.68	$194.02	$198.73	+60.77%
March, 2028	$194.40	$191.21	$198.73	+58.10%
April, 2028	$196.63	$193.88	$199.58	+59.91%
May, 2028	$183.31	$183.16	$198.77	+49.08%
June, 2028	$188.79	$183.79	$191.40	+53.53%
July, 2028	$190.64	$185.89	$191.35	+55.04%
August, 2028	$193.64	$190.02	$194.64	+57.48%
September, 2028	$199.20	$193.18	$199.94	+62.00%
October, 2028	$208.62	$199.38	$209.86	+69.67%
November, 2028	$211.68	$208.45	$212.45	+72.15%
December, 2028	$211.60	$208.73	$213.18	+72.09%

Halozyme Therapeutics Inc Stock (HALO) Price Forecast for 2029

The 2029 price forecast for Halozyme Therapeutics Inc Stock (HALO) is $235.31 on average, with a high prediction of $270.68 and a low estimate of $208.49. This represents an +91.37% increase from the previous price of $122.96.

Month	Average	Low	High	Change from today's price
January, 2029	$209.04	$208.49	$213.09	+70.01%
February, 2029	$218.50	$209.46	$219.57	+77.70%
March, 2029	$221.42	$218.09	$222.54	+80.08%
April, 2029	$219.53	$218.70	$225.02	+78.54%
May, 2029	$221.69	$219.50	$222.77	+80.29%
June, 2029	$230.73	$221.89	$231.47	+87.64%
July, 2029	$235.23	$231.55	$236.12	+91.31%
August, 2029	$236.03	$234.46	$237.36	+91.95%
September, 2029	$245.07	$236.15	$246.52	+99.31%
October, 2029	$255.54	$243.86	$256.20	+107.83%
November, 2029	$260.94	$255.96	$262.72	+112.22%
December, 2029	$269.95	$260.76	$270.68	+119.55%

Halozyme Therapeutics Inc Stock (HALO) Price Forecast for 2030

Halozyme Therapeutics Inc Stock (HALO) is expected to reach an average price of $287.22 in 2030, with a high forecast of $312.28 and a low forecast of $264.17. This signifies an +133.59% surge from the last price of $122.96.

Month	Average	Low	High	Change from today's price
January, 2030	$275.74	$270.56	$277.52	+124.25%
February, 2030	$275.53	$270.32	$278.35	+124.08%
March, 2030	$269.82	$266.70	$275.05	+119.44%
April, 2030	$271.08	$264.17	$283.56	+120.47%
May, 2030	$273.92	$270.97	$274.66	+122.77%
June, 2030	$283.50	$274.17	$284.49	+130.56%
July, 2030	$290.08	$284.30	$293.00	+135.91%
August, 2030	$300.40	$290.51	$300.45	+144.30%
September, 2030	$297.66	$293.85	$301.96	+142.08%
October, 2030	$307.64	$296.06	$312.28	+150.20%
November, 2030	$298.93	$290.00	$310.40	+143.11%
December, 2030	$302.31	$298.65	$302.56	+145.86%

Similar to HALO